Atypical amplification of chromosome region 22q12 in melanoma: A case report

Giuseppina Liguori, Monica Cantile, Francesca Collina, Laura Marra, Anna de Chiara, Renato Franco, Michele Caraglia, Gerardo Botti, Mirella D'Andrea, Giovanni Francesco Nicoletti

Research output: Contribution to journalArticle

Abstract

Morphological, ultrastructural and immunohistochemical characteristics of clear cell sarcoma (CCS) of the soft tissue frequently overlap with those of malignant melanoma. Thus, the differential diagnosis between the two lesions represents an important diagnostic dilemma. However, a number of genetic factors can be used to differentiate the two tumors; in particular, the t(12;22)(q13;q12) chromosomal translocation is typical of CCS, resulting in fusion of the EWSR1 gene on chromosome 22q12 and the ATF1 gene on chromosome 12q13. The detection of this molecular alteration has proved useful in the differential diagnosis of the two lesions. The present study reports the case of a 71-year-old male patient with a suspicious lymph node mass. Immunohistochemical analysis of the lesion indicated a diagnosis of metastatic melanoma, however, cytogenetic analysis using fluorescence in situ hybridization was additionally performed to investigate the chromosomal rearrangements of the 22q12 region and completely exclude the possibility of CCS. The current case did not demonstrate the presence of the translocation, supporting the diagnosis of melanoma. However, a clear orange amplification signal was observed relative to an ~500-kb region adjacent to the EWSR1 gene in the centromeric direction of chromosome 22q12. To the best of our knowledge, this is the first description of a 22q12 chromosomal alteration in melanoma. Furthermore, despite the presence of numerous genes in this region, their amplification has not previously been associated with the pathogenesis of melanoma.

Original languageEnglish
Pages (from-to)349-353
Number of pages5
JournalOncology Letters
Volume10
Issue number1
DOIs
Publication statusPublished - Jul 1 2015

Fingerprint

Clear Cell Sarcoma
Melanoma
Chromosomes
Differential Diagnosis
Genes
Genetic Translocation
Cytogenetic Analysis
Gene Fusion
Fluorescence In Situ Hybridization
Lymph Nodes
Neoplasms

Keywords

  • Chromosomal translocation
  • Clear cell sarcoma
  • Differential diagnosis
  • EWSR1 gene
  • Fluorescence in situ hybridization

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Atypical amplification of chromosome region 22q12 in melanoma : A case report. / Liguori, Giuseppina; Cantile, Monica; Collina, Francesca; Marra, Laura; de Chiara, Anna; Franco, Renato; Caraglia, Michele; Botti, Gerardo; D'Andrea, Mirella; Nicoletti, Giovanni Francesco.

In: Oncology Letters, Vol. 10, No. 1, 01.07.2015, p. 349-353.

Research output: Contribution to journalArticle

Liguori, G, Cantile, M, Collina, F, Marra, L, de Chiara, A, Franco, R, Caraglia, M, Botti, G, D'Andrea, M & Nicoletti, GF 2015, 'Atypical amplification of chromosome region 22q12 in melanoma: A case report', Oncology Letters, vol. 10, no. 1, pp. 349-353. https://doi.org/10.3892/ol.2015.3150
Liguori, Giuseppina ; Cantile, Monica ; Collina, Francesca ; Marra, Laura ; de Chiara, Anna ; Franco, Renato ; Caraglia, Michele ; Botti, Gerardo ; D'Andrea, Mirella ; Nicoletti, Giovanni Francesco. / Atypical amplification of chromosome region 22q12 in melanoma : A case report. In: Oncology Letters. 2015 ; Vol. 10, No. 1. pp. 349-353.
@article{b13b588ecc3248e69e081046ef67f46f,
title = "Atypical amplification of chromosome region 22q12 in melanoma: A case report",
abstract = "Morphological, ultrastructural and immunohistochemical characteristics of clear cell sarcoma (CCS) of the soft tissue frequently overlap with those of malignant melanoma. Thus, the differential diagnosis between the two lesions represents an important diagnostic dilemma. However, a number of genetic factors can be used to differentiate the two tumors; in particular, the t(12;22)(q13;q12) chromosomal translocation is typical of CCS, resulting in fusion of the EWSR1 gene on chromosome 22q12 and the ATF1 gene on chromosome 12q13. The detection of this molecular alteration has proved useful in the differential diagnosis of the two lesions. The present study reports the case of a 71-year-old male patient with a suspicious lymph node mass. Immunohistochemical analysis of the lesion indicated a diagnosis of metastatic melanoma, however, cytogenetic analysis using fluorescence in situ hybridization was additionally performed to investigate the chromosomal rearrangements of the 22q12 region and completely exclude the possibility of CCS. The current case did not demonstrate the presence of the translocation, supporting the diagnosis of melanoma. However, a clear orange amplification signal was observed relative to an ~500-kb region adjacent to the EWSR1 gene in the centromeric direction of chromosome 22q12. To the best of our knowledge, this is the first description of a 22q12 chromosomal alteration in melanoma. Furthermore, despite the presence of numerous genes in this region, their amplification has not previously been associated with the pathogenesis of melanoma.",
keywords = "Chromosomal translocation, Clear cell sarcoma, Differential diagnosis, EWSR1 gene, Fluorescence in situ hybridization",
author = "Giuseppina Liguori and Monica Cantile and Francesca Collina and Laura Marra and {de Chiara}, Anna and Renato Franco and Michele Caraglia and Gerardo Botti and Mirella D'Andrea and Nicoletti, {Giovanni Francesco}",
year = "2015",
month = "7",
day = "1",
doi = "10.3892/ol.2015.3150",
language = "English",
volume = "10",
pages = "349--353",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Atypical amplification of chromosome region 22q12 in melanoma

T2 - A case report

AU - Liguori, Giuseppina

AU - Cantile, Monica

AU - Collina, Francesca

AU - Marra, Laura

AU - de Chiara, Anna

AU - Franco, Renato

AU - Caraglia, Michele

AU - Botti, Gerardo

AU - D'Andrea, Mirella

AU - Nicoletti, Giovanni Francesco

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Morphological, ultrastructural and immunohistochemical characteristics of clear cell sarcoma (CCS) of the soft tissue frequently overlap with those of malignant melanoma. Thus, the differential diagnosis between the two lesions represents an important diagnostic dilemma. However, a number of genetic factors can be used to differentiate the two tumors; in particular, the t(12;22)(q13;q12) chromosomal translocation is typical of CCS, resulting in fusion of the EWSR1 gene on chromosome 22q12 and the ATF1 gene on chromosome 12q13. The detection of this molecular alteration has proved useful in the differential diagnosis of the two lesions. The present study reports the case of a 71-year-old male patient with a suspicious lymph node mass. Immunohistochemical analysis of the lesion indicated a diagnosis of metastatic melanoma, however, cytogenetic analysis using fluorescence in situ hybridization was additionally performed to investigate the chromosomal rearrangements of the 22q12 region and completely exclude the possibility of CCS. The current case did not demonstrate the presence of the translocation, supporting the diagnosis of melanoma. However, a clear orange amplification signal was observed relative to an ~500-kb region adjacent to the EWSR1 gene in the centromeric direction of chromosome 22q12. To the best of our knowledge, this is the first description of a 22q12 chromosomal alteration in melanoma. Furthermore, despite the presence of numerous genes in this region, their amplification has not previously been associated with the pathogenesis of melanoma.

AB - Morphological, ultrastructural and immunohistochemical characteristics of clear cell sarcoma (CCS) of the soft tissue frequently overlap with those of malignant melanoma. Thus, the differential diagnosis between the two lesions represents an important diagnostic dilemma. However, a number of genetic factors can be used to differentiate the two tumors; in particular, the t(12;22)(q13;q12) chromosomal translocation is typical of CCS, resulting in fusion of the EWSR1 gene on chromosome 22q12 and the ATF1 gene on chromosome 12q13. The detection of this molecular alteration has proved useful in the differential diagnosis of the two lesions. The present study reports the case of a 71-year-old male patient with a suspicious lymph node mass. Immunohistochemical analysis of the lesion indicated a diagnosis of metastatic melanoma, however, cytogenetic analysis using fluorescence in situ hybridization was additionally performed to investigate the chromosomal rearrangements of the 22q12 region and completely exclude the possibility of CCS. The current case did not demonstrate the presence of the translocation, supporting the diagnosis of melanoma. However, a clear orange amplification signal was observed relative to an ~500-kb region adjacent to the EWSR1 gene in the centromeric direction of chromosome 22q12. To the best of our knowledge, this is the first description of a 22q12 chromosomal alteration in melanoma. Furthermore, despite the presence of numerous genes in this region, their amplification has not previously been associated with the pathogenesis of melanoma.

KW - Chromosomal translocation

KW - Clear cell sarcoma

KW - Differential diagnosis

KW - EWSR1 gene

KW - Fluorescence in situ hybridization

UR - http://www.scopus.com/inward/record.url?scp=84929906714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929906714&partnerID=8YFLogxK

U2 - 10.3892/ol.2015.3150

DO - 10.3892/ol.2015.3150

M3 - Article

AN - SCOPUS:84929906714

VL - 10

SP - 349

EP - 353

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 1

ER -